Results 281 to 290 of about 154,650 (346)

Chronic Intermittent Hypoxia and MASLD in Obstructive Sleep Apnea: A Critical Appraisal of Mechanistic and Causal Evidence. [PDF]

open access: yesInt J Mol Sci
Cebuc Simeanu GM   +17 more
europepmc   +1 more source

Erythritol and metabolic dysfunction‐associated steatotic liver disease: A sweet friend, bitter foe, or reliable fellow traveler?

open access: yes
Journal of Diabetes Investigation, EarlyView.
Kelly Hiu‐Ching Wong   +2 more
wiley   +1 more source

Nonalcoholic Steatohepatitis: A Review.

JAMA, 2020
Importance Nonalcoholic steatohepatitis (NASH) is the inflammatory subtype of nonalcoholic fatty liver disease (NAFLD) and is associated with disease progression, development of cirrhosis, and need for liver transplant.
A. Sheka   +5 more
semanticscholar   +3 more sources

Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma: Pathogenesis and Treatment

open access: yesNature Reviews Gastroenterology and Hepatology, 2023
In this Review, Llovet and colleagues discuss advances in our knowledge of the pathogenesis and clinical management of nonalcoholic steatohepatitis-related hepatocellular carcinoma. They also discuss future prospects and unmet needs.
Hashem El Serag   +2 more
exaly   +2 more sources

Liraglutide Safety and Efficacy in Patients With Non-Alcoholic Steatohepatitis (LEAN): A Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase 2 Study

open access: yesLancet, The, 2016
BACKGROUND Glucagon-like peptide-1 (GLP-1) analogues reduce hepatic steatosis, concentrations of liver enzymes, and insulin resistance in murine models of fatty liver disease.
Rachel M Brown   +2 more
exaly   +2 more sources

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

open access: yesNew England Journal of Medicine, 2010
BACKGROUND Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease.
Arun Sanyal   +2 more
exaly   +2 more sources

Nonalcoholic Steatohepatitis

Annals of Internal Medicine, 1997
To determine the clinical relevance of nonalcoholic steatohepatitis (NASH) and to review the available literature on the epidemiology, clinical features, histology, pathogenesis, clinical course, and management of this condition.Pertinent articles in English identified through a MEDLINE search (1966 to the present) and the bibliographies of relevant ...
S G, Sheth, F D, Gordon, S, Chopra
openaire   +4 more sources

Therapeutic Pipeline in Nonalcoholic Steatohepatitis

Nature Reviews Gastroenterology and Hepatology, 2021
Arun Sanyal   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy